| Product Code: ETC6175648 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Bipolar Disorder Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Bipolar Disorder Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Bipolar Disorder Market - Industry Life Cycle |
3.4 Australia Bipolar Disorder Market - Porter's Five Forces |
3.5 Australia Bipolar Disorder Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Australia Bipolar Disorder Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
4 Australia Bipolar Disorder Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about mental health issues in Australia |
4.2.2 Rising prevalence of bipolar disorder in the country |
4.2.3 Advancements in treatment options and therapies for bipolar disorder patients |
4.3 Market Restraints |
4.3.1 Stigma associated with mental health disorders leading to underreporting and underdiagnosis |
4.3.2 Limited access to mental health services, including specialized care for bipolar disorder patients |
4.3.3 High costs associated with long-term management of bipolar disorder |
5 Australia Bipolar Disorder Market Trends |
6 Australia Bipolar Disorder Market, By Types |
6.1 Australia Bipolar Disorder Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Australia Bipolar Disorder Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Australia Bipolar Disorder Market Revenues & Volume, By Mood stabilizer, 2021- 2031F |
6.1.4 Australia Bipolar Disorder Market Revenues & Volume, By Anticonvulsants, 2021- 2031F |
6.1.5 Australia Bipolar Disorder Market Revenues & Volume, By Antipsychotic drugs, 2021- 2031F |
6.1.6 Australia Bipolar Disorder Market Revenues & Volume, By Antidepressant drugs, 2021- 2031F |
6.2 Australia Bipolar Disorder Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 Australia Bipolar Disorder Market Revenues & Volume, By Selective serotonin reuptake inhibitor, 2021- 2031F |
6.2.3 Australia Bipolar Disorder Market Revenues & Volume, By Serotonin norepinephrine reuptake inhibitor, 2021- 2031F |
6.2.4 Australia Bipolar Disorder Market Revenues & Volume, By Tricyclic antidepressant drugs, 2021- 2031F |
6.2.5 Australia Bipolar Disorder Market Revenues & Volume, By Monoamine oxidase inhibitors, 2021- 2031F |
6.2.6 Australia Bipolar Disorder Market Revenues & Volume, By Benzodiazepines, 2021- 2031F |
6.2.7 Australia Bipolar Disorder Market Revenues & Volume, By Beta blockers, 2021- 2031F |
7 Australia Bipolar Disorder Market Import-Export Trade Statistics |
7.1 Australia Bipolar Disorder Market Export to Major Countries |
7.2 Australia Bipolar Disorder Market Imports from Major Countries |
8 Australia Bipolar Disorder Market Key Performance Indicators |
8.1 Number of individuals seeking mental health services in Australia |
8.2 Percentage of diagnosed bipolar disorder cases receiving appropriate treatment |
8.3 Research and development investments in new therapies for bipolar disorder |
9 Australia Bipolar Disorder Market - Opportunity Assessment |
9.1 Australia Bipolar Disorder Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Australia Bipolar Disorder Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
10 Australia Bipolar Disorder Market - Competitive Landscape |
10.1 Australia Bipolar Disorder Market Revenue Share, By Companies, 2024 |
10.2 Australia Bipolar Disorder Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here